N-substituted oxazinopteridines and oxazinopteridinones
    3.
    发明授权
    N-substituted oxazinopteridines and oxazinopteridinones 有权
    N-取代的恶嗪腙和氧杂哒嗪酮

    公开(公告)号:US08791107B2

    公开(公告)日:2014-07-29

    申请号:US13404958

    申请日:2012-02-24

    IPC分类号: A61K31/5383 C07D498/14

    摘要: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein Ar, R1, R2, R3, G1, G2, and m are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating inflammatory disorders, cardiovascular disease, cancer, and other conditions associated with PI3Kδ.

    摘要翻译: 公开了式1的化合物及其药学上可接受的盐,其中Ar,R1,R2,R3,G1,G2和m在说明书中定义。 本公开还涉及用于制备式1化合物的材料和方法,含有它们的药物组合物及其用于治疗与PI3Kδ相关的炎性疾病,心血管疾病,癌症和其它病症的用途。

    MAPK/ERK kinase inhibitors
    8.
    发明授权
    MAPK/ERK kinase inhibitors 有权
    MAPK / ERK激酶抑制剂

    公开(公告)号:US08293901B2

    公开(公告)日:2012-10-23

    申请号:US12520247

    申请日:2007-12-18

    CPC分类号: C07D471/04

    摘要: Compounds of the following formula are provided for use with MEK (I): wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

    摘要翻译: 提供下式的化合物用于MEK(I):其中变量如本文所定义。 还提供了包含这些化合物的药物组合物,试剂盒和制品; 用于制备化合物的方法和中间体; 以及使用所述化合物的方法。

    HEXAHYDROOXAZINOPTERINE COMPOUNDS
    10.
    发明申请
    HEXAHYDROOXAZINOPTERINE COMPOUNDS 有权
    十六氢X嗪化合物

    公开(公告)号:US20120178924A1

    公开(公告)日:2012-07-12

    申请号:US13429865

    申请日:2012-03-26

    IPC分类号: C07D498/14

    CPC分类号: C07D498/14

    摘要: The present invention relates to intermediates of the formula wherein G1 is N; G2 is selected from the group consisting of C═O and CH2; X is a halogen; and the other groups are defined herein.

    摘要翻译: 本发明涉及下式的中间体,其中G1是N; G2选自C = O和CH 2; X是卤素; 并且其他组在本文中定义。